Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RIA Generics is a pharmaceutical company dedicated to the development and commercialization of generic prescription medications for the United States healthcare market. Based in Parsippany, New Jersey, the company focuses on delivering cost-effective therapeutic options across a range of medical specialties, including gastroenterology and musculoskeletal health. Their product portfolio features essential generic drugs such as dicyclomine hydrochloride and methocarbamol, manufactured in compliance with stringent regulatory standards. RIA Generics leverages a robust supply chain and strategic partnerships to ensure the consistent availability of high-quality pharmaceuticals to wholesalers and pharmacies. By prioritizing affordability and reliability, the company plays a vital role in expanding patient access to critical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RIA Generics.